Vol. 5 No. 01 (2021)
Original Article

ENT manifestation in extrapulmonary tuberculosis

Md Azadur Rahman
Assistant Professor (ENT)
Mst. Tamanna Begum
Medical Officer, Chest Disease Hospital, Sylhet, Bangladesh
Md. Monharul Islam Bhuiya
Assistant Professor (Medicine), Sylhet Women’s Medical College, Sylhet, Bangladesh
Pros and Cons of Covid-19 Vaccines – an editorial

Published 20-09-2021

Keywords

  • ENT manifestation,
  • extrapulmonary tuberculosis (EPTB),
  • laryngeal tuberculosis

How to Cite

1.
ENT manifestation in extrapulmonary tuberculosis . Planet (Barisal) [Internet]. 2021 Sep. 20 [cited 2024 Nov. 24];5(01):5. Available from: https://bdjournals.org/index.php/planet/article/view/13

Abstract

Objective: In this study our main goal is to evaluate the ENT manifestation in extrapulmonary tuberculosis patients. Method: This cross-sectional study was carried out at Sylhet Women’s Medical College from 19th August 2019 to 18th August 2020. A total 150 patients included in the study, hospitalized for investigation for pyrexia of unknown origin and clinically suspected extrapulmonary tuberculosis patients. Results: During the study, more than fifty percent (56.0%) of the patients were in the age group 20-40 years and 30.0% of the patients were in age group 20 and below while only 14.0% of the patients were in the age group above 40 years. Also, male and female ratio of the patients was almost equal. About three fifths of the patients had history of smoking. One tenth of the patients had the history of alcohol consumption. During the study extrapulmonary tuberculosis vertical cases were found in 90% followed by laryngeal tuberculous mastoiditis found in 3% cases and Cervical Abscess found in 7% cases. Conclusion: The practical implications of an awareness of ENT extrapulmonary tuberculosis are a benefit of anti-tubercular therapy and hence conservative management usually suffices.

References

  1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva: WHO, 2008. http://whqlibdoc.who.int/publication
  2. s/2008/9789241563543_eng.pdf - accessible 6 January 2012.
  3. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004; 8(5): 636–47
  4. Helmy NA, Eissa SA, Masoud HH, Elessawy AF, Ahmed RI. Diagnostic value of adenosine deaminase in tuberculous and malignant pleural effusion Egyptian Journal of Chest Diseases and Tuberculosis (2012) 61, 413–417
  5. Valdes L, Pose A, San Jose E, Martinez Vazquez JM. Tuberculous pleural effusions. Eur J Intern Med. 2003 Mar; 14(2): 77-88.
  6. Soda A, Rubio H, Salazar M, Ganem J, Berlanga D,Sanchez A. Tuberculosis of the larynx: clinical aspects of 19patients.Laryngoscope1989;99:114 7–50
  7. Vidal R, Mayordomo C, Miravitlles M, Marti S, Torrella M,Lorente J. Pulmonary and laryngeal tuberculosis: a study of 26 patients.RevClinEsp1996;196:378–80
  8. Manni JJ. The prevalence of tubercuous laryngitis inpulmonary tuberculosis in Tanzanians.Trop Geogr Med1982;34:159–62